Pharmacy and Poisons Board offices along Lenana Road in Nairobi. The building was officially opened in 2005 by the Minister of Health at the time, Hon. Charity Ngilu.
Pharmacovigilance department came out to the Kenyan public on the 9th of June 2009 when a formal launch of the Pharmacovigilance System in Kenya took place at the Panafric Hotel in Nairobi.
National Quality Control Laboratory. The quality of a drug is one of the criteria for market approval. Quality assurance covers all activities aimed at ensuring that consumers and patients receive a product that meets established specifications and standards of quality, safety an efficacy.
Ministry of Health HQ
Pharmacy and Poisons Board is under the Ministry of Health whose HQ are at Afya House, Bishop Road, Nairobi
The Pharmacy and Poisons Board has various guidelines that explain how services are delivered. The guidelines can be downloaded from this site.
The Department of Pharmacovigilance
The Department of Pharmacovigilance was set up in late 2004 at the Pharmacy and Poisons Board with a vision to develop, implement and continuously upgrade an appropriate system for detecting, reporting and monitoring adverse drug reactions (ADRs) and other relevant problems with medicines in Kenya. The department strives to ensure the safety and efficacy of pharmaceutical products in Kenya. The department also carries out routine post market surveillance on all medicines in Kenya.
Pharmacovigilance is the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other possible drug-related problems with the view to:
Early detection of hitherto unknown adverse reactions and interactions
Detection of increases in frequency of (known) adverse reactions
Identification of risk factors and possible mechanisms underlying adverse reactions
Estimation of quantitative aspects of benefit/risk analysis and dissemination of information needed to improve drug prescribing and regulation.
The ultimate goals of Pharmacovigilance are:
- The rational and safe use of medicines
- The assessment and communication of the risks and benefits of drugs on the market
- Educating and informing patients.
Guidelines and the tools to implement Pharmacovigilance in Kenya have been developed and sensitization workshops have been carried out for various cadres of health professionals in Kenya such as Pharmacists, Pharmaceutical technologists, nurses, Clinicians and Clinical officers. The system plans to cover all provinces, for all medicines and for all patients. All manufacturers and distributors are expected to submit all findings and reports on adverse events with drugs to PPB.